Stratigos A, Sekulic A, Peris K, Bechter O, Kaatz M, Lewis K, Basset-Segiun N, Chang AL, Dalle S, Orland AF, Licitra L, Robert C, Ulrich C, Hauschild A, Migden M, Dummer R, Li S, Mohan K, Coates E, Jankovic V, Flaschi N, Okoye E, Bassukas I, Loquai C, De Giorgi V, Eroglu Z, Gutzmer R, Ulrich J, Puig S, Seebach F, Thurston G, Lowy I, Bowler T, Fury M. Primary Analysis of Phase 2 Results for Cemiplimab in Patients (pts) with Locally Advanced Basal Cell Carcinoma (laBCC) who Progress on or are Intolerant to Hedgehog Inhibitors (HHIs). J of Skin [Internet]. 2021Jan.1 [cited 2024Jul.22];5(1):s4. Available from: https://jofskin.org/index.php/skin/article/view/1156